Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties
Peter Dreger*, Mauricette Michallet, Paul Bosman, Sascha Dietrich, Mohamad Sobh, Ariane Boumendil, Arnon Nagler, Christof Scheid, Jan Cornelissen, Dietger Niederwieser, Lutz Mueller, Elizabeth Vandenberghe, Ilaria Scortechini, Helene Schoemans, Niels S. Andersen, Juergen Finke, Domenico Russo, Per Ljungman, Jakob Passweg, Michel van GelderNadira Durakovic, Helene Labussiere-Wallet, Tobias Berg, Gerald Wulf, Wolfgang Bethge, Donald Bunjes, Stefan Stilgenbauer, Maria Elisa Canepari, Michel Schaap, Christopher P. Fox, Nicolaus Kroeger, Silvia Montoto, Johannes Schetelig
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties'. Together they form a unique fingerprint.